The Intelligent Enterprise – Balancing Opportunity, Risk, and the Ethical Imperative of AI Adoption
The International Journal of Humanities, Social Sciences and Business Management · 2025
DOI: 10.62896/ijhsbm.v1.i4.02 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Humanities, Social Sciences and Business Management, 2025. Verfasst von Mohammed Abdul Jaleel.
Abstract (Originalsprache)
The integration of Artificial Intelligence (AI) and Generative AI (GenAI) is rapidly redefining the commercial landscape, offering unprecedented Opportunities for operational efficiency, innovation, and personalized customer engagement. However, this transformative technology introduces significant Risks across data security, financial stability, and workforce disruption, alongside profound Ethical Implications concerning bias, accountability, and transparency. These editorial asserts that success in the AI-driven economy hinges not merely on technological adoption speed, but on the implementation of a rigorous, ethically governed framework. Businesses must move beyond pilot projects to integrate AI strategically, invest heavily in workforce reskilling, and proactively embed principles of Responsible AI (RAI) to preserve customer trust and mitigate substantial legal and reputational exposure.
Zitieren
APA
Jaleel, M. A. (2025). The Intelligent Enterprise – Balancing Opportunity, Risk, and the Ethical Imperative of AI Adoption. The International Journal of Humanities, Social Sciences and Business Management. https://doi.org/10.62896/ijhsbm.v1.i4.02
Vancouver
Jaleel MA. The Intelligent Enterprise – Balancing Opportunity, Risk, and the Ethical Imperative of AI Adoption. The International Journal of Humanities, Social Sciences and Business Management. 2025. doi:10.62896/ijhsbm.v1.i4.02
BibTeX
@article{Jaleel2025,
author = {Jaleel, Mohammed Abdul},
title = {The Intelligent Enterprise – Balancing Opportunity, Risk, and the Ethical Imperative of AI Adoption},
journal = {The International Journal of Humanities, Social Sciences and Business Management},
year = {2025},
doi = {10.62896/ijhsbm.v1.i4.02}
}
EUVIMED